Generic Crizotinib for Lung Cancer - Affordable Alternative to Xalkori®

Generic Crizotinib for Lung Cancer - Affordable Alternative to Xalkori®

Summary - Crizotinib (Xalkori®) is an effective treatment for non-small cell lung cancer but costs over $23,000 for a month's supply in the US. MedsPartner offers high-quality generic crizotinib at ~98% savings globally through legal personal imports. This article explains steps for accessing affordable targeted lung cancer therapy worldwide.

Non-small cell lung cancer (NSCLC) with ALK or ROS1 genetic mutations requires targeted treatment. Early detection of these mutations opens doors to more effective treatment options than standard chemotherapy.

Crizotinib was the first ALK inhibitor - revolutionizing treatment for individuals with these specific genetic mutations. It specifically targets cancer cells while causing fewer side effects than conventional chemotherapy.

But high costs prevent many patients from trying this medicine. No generic option is there in the United States and many other countries. However, generics from credible FDA/EMA-approved Indian manufacturers provide real relief. MedsPartner helps patients across 45+ countries - from the USA and UK to Australia and New Zealand - with low-cost generic crizotinib. This guide answers frequently asked questions about safely importing prescription medicines.

What is Crizotinib’s mechanism of action to treat lung cancer? 

In patients with ALK-positive or ROS1-positive NSCLC, genetic mutations cause abnormal proteins that drive cancer cell growth. 

Crizotinib works by blocking these abnormal ALK and ROS1 proteins. It thereby stops the growth signals from reaching cancer cells. This targeted approach starves cancer cells while leaving normal cells largely unaffected - slowing down lung cancer for months or even years.

Latest updates on Crizotinib and lung cancer treatment

Generic crizotinib now available internationally

Multiple manufacturers produce generic crizotinib globally, particularly in India. However, no generic is present in the US market as of now. Branded Xalkori® is the only option in the United States. Generics from Indian manufacturers are priced significantly lower while offering the same active ingredient.

Newer ALK inhibitors approved

Since crizotinib's approval, several new ALK inhibitors have launched - including alectinib, brigatinib, and lorlatinib. Despite newer options, crizotinib remains widely prescribed due to its established efficacy.

Crizotinib price - Why does Xalkori® remain expensive?

The branded version comes at a premium price due to patent protection and high development cost of targeted drugs.

No US generic exists yet, as a result local prices are extraordinarily high. Insurance typically covers crizotinib but often requires prior authorization and carries substantial copays for this specialty oncology medication. 

Reputed manufacturers in India produce generic crizotinib at much lower prices. MedsPartner sources from FDA/EMA-approved manufacturers in India to provide affordable generic crizotinib. These generics have the same active ingredient and benefits at a small percentage of US prices.

What savings can I expect with generic Crizotinib from MedsPartner?

Source

Price (USD)

Xalkori® 200mg branded (US)

$23,229.46 for 60 capsules

US generic crizotinib

Not available (patent protection)

MedsPartner's generic 200mg

$470 for 60 capsules

Branded Xalkori® 200mg costs approximately $23,230 for 60 capsules in the United States. No generic alternative exists domestically. In contrast, MedsPartner's generic crizotinib costs $235 for 30 capsules, which works out to approximately $470 per month. This sums up to savings of  $22,759 or ~98% compared to branded versions.

Is importing generic low-cost Crizotinib from another country legal?

Yes, this process is called personal importation and is allowed by many nations. If you have a serious condition and local options are unaffordable / unavailable - your country may allow personal import from an international source for personal use, with a valid prescription and quantity limits.

MedsPartner has shipped high-quality generic medicines from India to patients in over 45 countries over the last decade. We take care of the essential paperwork for each geography - be it US, UK, Australia, New Zealand, or others. We have handled 30,000+ fulfilled deliveries of life-saving meds. Our process offers end-to-end support, starting with confirming your country’s personal import laws and then fulfilling your order in a compliant way. 

How a lung cancer patient in Malaysia accessed affordable Crizotinib generic through MedsPartner

Stacy found out she has ALK-positive non-small cell lung cancer at age 42. Her oncologist recommended crizotinib after genetic testing revealed the ALK mutation. 

In Malaysia, while Xalkori® is available through oncology centers, the cost was too much for her family. Even with partial insurance coverage, the out-of-pocket expenses exceeded what they could afford.

Stacy decided to explore international sourcing options after speaking to a few patient advocates. With proper documentation and prescriptions, she accessed quality-assured generic crizotinib through MedsPartner.

This made continuing her effective treatment financially feasible for the long term.

This is one of many such success stories from around the world. We are glad to aid patients in 45+ countries with essential medicines when local options run out.

Answering your FAQs about Crizotinib

Q1. What makes MedsPartner's generic Crizotinib reliable?

A - MedsPartner sources generic crizotinib exclusively from an FDA/EMA-approved manufacturer in India. These generics contain the same active ingredient and are proven to give comparable benefits as branded versions. We provide complete manufacturer details and expiry dates with every order, so you know exactly where your medicine comes from. Our experience of 9+ years and 30,000+ successful deliveries spans over 45 nations - including USA, UK, NZ, and AU. We have many positive reviews from customers, with a  4.7-star rating on TrustPilot.

Q2. My insurance denied coverage for Crizotinib - what are my options?

A - Insurance denials are tough yet common. In this scenario, you can appeal with detailed medical documentation including genetic testing results showing ALK or ROS1 positivity and explaining why crizotinib is medically necessary. Pfizer has patient assistance programs that may help eligible patients and you can also check support programs run by orgs like PAN foundation. For patients that are ineligible for these options, generic crizotinib through MedsPartner's compliant importation program offers ~98% savings compared to US pricing.

Q3. How do I order generic Crizotinib from MedsPartner?

A - Visit MedsPartner's crizotinib product page and provide your prescription - no payment needed yet. Our team checks the prescription and reviews your country's importation laws. After confirmation, we shall provide you the final pricing details and answer any queries. Post successful payment, we process the order and ship the medicine sourced from an FDA/EMA-approved manufacturer to your doorstep.

Q4. As an oncologist, how can I help my patient purchase affordable Crizotinib?

A - Oncologists can reach out on support@medspartner.com with the details. We work directly with patients and offer them the medicines they need via legal personal imports as per their prescription. We will contact your patient to help them with the whole process.

Q5. Are there any side effects of Crizotinib I should expect?

A - Vision changes are common with crizotinib - flashes of light, blurred vision, or trouble seeing in low light. These usually settle over time. Nausea, diarrhea, and vomiting often happen early in treatment. Swelling in the arms or legs is also common. Doctors keep an eye on liver function and blood counts, since liver enzymes can rise and infection risk may increase. Rare but serious side effects include lung inflammation, heart rhythm issues (QT prolongation), severe liver problems, and sometimes kidney cysts. Your doctor will monitor and manage these as needed.

Q6. How much can I save by opting for MedsPartner's generic Crizotinib?

A - At standard dosing of 250mg twice daily (60 capsules monthly), branded Xalkori® costs approximately $23,230 per month. MedsPartner's generic crizotinib costs about $470 per month . That's around $22,759 in monthly savings, or a 98% cost reduction. Since ALK-positive NSCLC treatment continues long-term, these savings add up significantly.

Targeted lung cancer therapy shouldn't come with financial burden

Crizotinib offers real hope to ALK-positive and ROS1-positive lung cancer patients. But monthly bills exceeding $23,000 are impossible for many to afford. MedsPartner eliminates that barrier by providing patients high quality generic crizotinib at much more reasonable prices. We've helped thousands of lung cancer patients continue their targeted therapy without mounting bills.

Looking for affordable crizotinib solutions? Contact us at support@medspartner.com. You can also place your order on our website. We help you procure the targeted therapy your oncologist prescribed at costs that won't overwhelm your family's finances.

About The Author - Atul Goyal combines operational insight with a strong understanding of global healthcare systems - honed through years of managing complex pharmaceutical supply chains. At MedsPartner - he leads efforts to streamline international medicine deliveries, balancing efficiency, compliance & patient affordability. His experience spans logistics, pricing strategy & regulatory frameworks - enabling him to effectively navigate the evolving landscape of global medicine access.

 

Volver al blog